April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Katy Beckermann: The role of belzutifan in treating rare mutation VHL congenital-related polycythemia
Dec 3, 2024, 18:58

Katy Beckermann: The role of belzutifan in treating rare mutation VHL congenital-related polycythemia

Katy Beckermann, Assistant Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine, at Vanderbilt University Medical Center, shared on X:

Excited to share this case report led by the brilliant Paulo Amaral! It highlights the role of belzutifan in treating rare mutation VHL congenital-related polycythemia, showcasing its efficacy and safety.

Von Hippel-Lindau syndrome-related congenital polycythemia and response to belzutifan

Authors: Paulo Siqueira do Amaral, Sanjay R. Mohan, Kathryn E. Beckermann

Katy Beckermann: The role of belzutifan in treating rare mutation VHL congenital-related polycythemia